Mean platelet volume as a Low-Cost discriminatory marker for thrombotic risk assessment in Yemeni type 2 diabetic patients: A proposal for Resource-Limited settings
Open Access
- 29 January 2026
- journal article
- research article
- Published by Springer Nature in Conflict and Health
- Vol. 20 (1)
Abstract
Thrombotic complications are a leading cause of mortality in type 2 diabetes mellitus (T2DM). In resource-limited settings, identifying affordable and acceKeywords
This publication has 12 references indexed in Scilit:
- What the neighbors sayJournal of Thrombosis and Haemostasis, 2022
- The Prognostic Utility of Mean Platelet Volume in Patients With Acute Coronary Syndrome: A Systematic Review With Meta-AnalysesAngiology, 2022
- Risk factors for major adverse cardiovascular events after the first acute coronary syndromeAnnals of Medicine, 2021
- Type 2 diabetes mellitusNature Reviews Disease Primers, 2015
- Proposal of a score combining red blood cell indices for early differentiation of beta‐thalassemia minor from iron deficiency anemiaHematology, 2011
- PlateletsArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Factors Contributing to Increased Platelet Reactivity in People With DiabetesDiabetes Care, 2009
- Diabetes mellitus as a prothrombotic conditionJournal of Internal Medicine, 2007
- Presence of antithrombin antibody in atherosclerosis patients negative for antiprothrombin antibody, anticardiolipin antibody and lupus anticoagulantThrombosis Research, 2007
- Mean platelet volume in patients with metabolic syndrome and its relationship with coronary artery diseaseThrombosis Research, 2007